A SUV39H1-low chromatin state characterises and promotes migratory properties of cervical cancer cells-Reference-Cited by-同舟云学术

A SUV39H1-low chromatin state characterises and promotes migratory properties of cervical cancer cells

Published:2019-05 Issue:2 Volume:378 Page:206-216
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Rodrigues Calvin,Pattabiraman Chitra,Vijaykumar Anjali,Arora Reety,Narayana Suma Mysore,Kumar Rekha V.,Notani Dimple,Varga-Weisz Patrick,Krishna Sudhir

Funder

DBT

NCBS

TIFR

ICGEB

EMBL

Infosys Foundation

Boehringer Ingelheim Fonds

EACR

Wellcome Trust

Publisher

Elsevier BV

Subject

Cell Biology

Reference37 articles.

1. Human papillomavirus oncoproteins: pathways to transformation;Moody;Nat. Rev. Cancer,2010

2. Notch signaling in CD66+ cells drives the progression of human cervical cancers;Bajaj;Cancer Res.,2011

3. CD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traits;Pattabiraman;Cancer Res,2014

4. CD66 and CD49f expressing cells are associated with distinct neoplastic phenotypes and progression in human cervical cancer;Ammothumkandy;Eur. J. Cancer,2016

5. Chromatin-modifying enzymes as modulators of reprogramming;Onder;Nature,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CHROMO domain readers: A rainbow of opportunities;Chromatin Readers in Health and Disease;2024

2. SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma;BMC Cancer;2023-11-28

3. Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function;Cancer Discovery;2023-10-31

4. An updated review on the significance of DNA and protein methyltransferases and de-methylases in human diseases: From molecular mechanism to novel therapeutic approaches;Current Medicinal Chemistry;2023-06-07

5. Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer;International Journal of Medical Sciences;2022